Joshua Lehrer-Graiwer
CIK: 0001789673
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Lehrer-Graiwer Joshua
Lehrer-Graiwer Joshua (SEC CIK 0001789673) files insider reports with the SEC as President & COO of LISATA THERAPEUTICS, INC. (LSTA) and Director of Fulcrum Therapeutics, Inc. (FULC).
Signal8 holds 3 ownership filings by Lehrer-Graiwer Joshua (2 Form 3, 1 Form 4), filed between May 1, 2026 and Sep 28, 2026. Those filings report 1 transaction, the latest on Apr 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lehrer-Graiwer Joshua's filings is in LIBERTY CORNER, NJ.
Recent filings by Lehrer-Graiwer Joshua
- Apr 23, 2026: Grant or award of FULC derivative securities (Form 4, code A).
Other insiders filing for LISATA THERAPEUTICS, INC. (LSTA)
- Farrow Jeffrey S, Director
- LOVE TED W, Director
- Mazzo David J, President & CEO
- Nisco James, SVP, Fin/Treas, Chief Actg Off
- Imam Tariq, SVP, Bus Dev, General Counsel
- Buck Kristen K, EVP, R&D and CMO